Key result
Synthesized V8-V9 elevation in inferior STEMI is linked to ~2-fold higher peak CK levels.
Why the study?
Is synthesized V8-V9 ST-segment elevation associated with greater peak serum creatine kinase and worse in-hospital clinical outcomes in patients with inferior STEMI undergoing emergency PCI?
Cohort (n=209)
Is synthesized V8-V9 ST-segment elevation associated with greater peak serum creatine kinase and worse in-hospital clinical outcomes in patients with inferior STEMI undergoing emergency PCI?
In patients with inferior STEMI undergoing emergency PCI, synthesized V8-V9 ST-segment elevation derived from a standard 12-lead ECG identifies those with significantly greater myocardial injury and higher rates of ventricular arrhythmias and cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Synthesized V8-V9 elevation may aid risk stratification in inferior STEMI; leaves open whether it should guide therapy pending prospective validation.
Posterior involvement in inferior ST-segment elevation myocardial infarction (STEMI) is associated with greater myocardial injury and adverse outcomes. However, posterior leads are not routinely recorded because they require additional electrode placement. A synthesized 18-lead electrocardiogram (ECG) derives posterior leads from a standard 12-lead ECG without additional electrode placement. We investigated the clinical significance of synthesized V8-V9 ST-segment elevation in inferior STEMI. We retrospectively evaluated 209 patients with inferior STEMI who underwent successful emergency percutaneous coronary intervention (PCI) between January 2016 and December 2025. Patients were classified according to the presence of ST-segment elevation ≥ 0.1 mV in both synthesized V8 and V9 leads. The primary endpoint was peak serum creatine kinase (CK), which was log-transformed for multivariable analysis. Secondary endpoints included echocardiographic parameters and in-hospital clinical outcomes. Among 209 patients, 100 (47.8%) had synthesized V8-V9 ST-segment elevation and 109 (52.2%) did not. Peak CK was significantly higher in patients with V8-V9 ST-segment elevation than in those without (2925 [1341-4052] vs. 1384 [762-2443] U/L, P < 0.001). Chronic-phase E/e' was also significantly higher in the V8-V9 ST-segment elevation group (12.6 ± 4.9 vs. 10.6 ± 4.0, P = 0.01). Ischemic ventricular tachycardia/fibrillation (VT/VF) (13.0% vs. 3.7%, P = 0.01) and cardiogenic shock requiring mechanical circulatory support (20.0% vs. 9.2%, P = 0.04) were more frequent in patients with V8-V9 ST-segment elevation. In multivariable analysis, synthesized V8-V9 ST-segment elevation and age were independently associated with log-transformed peak CK. Synthesized V8-V9 ST-segment elevation was associated with greater myocardial injury and higher observed rates of ischemic VT/VF and cardiogenic shock requiring mechanical circulatory support. These clinical-outcome findings are exploratory, and further studies are needed to determine whether synthesized posterior leads provide incremental information beyond conventional ECG findings and clinical assessment.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2026) conducted a cohort in Inferior ST-segment elevation myocardial infarction (STEMI) (n=209). Synthesized V8-V9 ST-segment elevation (≥0.1 mV in both leads) vs. Absence of synthesized V8-V9 ST-segment elevation was evaluated on Peak serum creatine kinase (CK) (p=<0.001). Synthesized V8-V9 ST-segment elevation in inferior STEMI was associated with higher peak serum creatine kinase compared to no V8-V9 elevation.
Synapse has enriched 10 related papers. Consider them for comparative context: